Divi's Laboratories Ltd. (DIVISLAB) Share Price Hits Fresh 52-Week High

Divi's Laboratories Ltd. Share Price surged to Rs 8,462, marking a 5.03% rise and a fresh 52-week high of Rs 8,495. Market cap stands at Rs 2,13,878.74 crore.

Divi's Laboratories Ltd. Share Price has reached a new milestone, hitting a fresh 52-week high of Rs 8,495. The stock closed at Rs 8,462, reflecting a significant increase of 5.03% from the previous close of Rs 8,056.65. With a market capitalisation of Rs 2,13,878.74 crore, Divi's Laboratories Ltd. has captured investor attention. This event signifies strong market interest, although the exact catalyst remains unspecified in the available data. Investors are keenly observing the stock's performance, given its prominent position in the healthcare sector.

Divi's Laboratories Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 8,462
Previous Close	Rs 8,056.65
Today's Change	+Rs 405.35 (+5.03%)
Day Open	Rs 8,321.05
Fresh 52-Week High	Rs 8,495
Day Low	Rs 8,108.1
Current Volume	87,322
Turnover	Rs 73.89 crore
Market Capitalisation	Rs 2,13,878.74 crore

Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 8,462. versus the previous close of Rs 8,056.65, a rise of 5.03%. The stock opened at Rs 8,321.05, reached Rs 8,495, touched Rs 8,108.1. Reported volume was 87,322.

Today, Divi's Laboratories Ltd. opened at Rs 8,321.05 and reached a high of Rs 8,495, setting a fresh 52-week high. The stock's low for the day was Rs 8,108.1, and it closed at Rs 8,462, marking a day change of Rs 405.35 or 5.03%. The turnover for the day was Rs 73.89 crore, with a volume of 87,322 shares traded, indicating robust market participation. This price action highlights the stock's upward momentum, drawing attention to its valuation and financial metrics.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,13,878.74 crore
P/E Ratio	30.09x
P/B Ratio	0.44x
ROE	-2.89%
ROCE	-0.26%

Divi's Laboratories Ltd. was valued at a P/E ratio of 30.09x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	30.09x
Benchmark Median P/E	20.73x
Benchmark Average P/E	67.98x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	0.44x
Benchmark Median P/B	1.91x
Company ROE	-2.89%
Benchmark Median ROE	10.7%
Company ROCE	-0.26%
Benchmark Median ROCE	13.13%
Company Market Capitalisation	Rs 2,13,878.74 crore
Benchmark Median Market Cap	Rs 130.49 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 30.09x, which is above the benchmark median of 20.73x, a difference of +45.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.13%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,931.84	30.09	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,683.28	39.84	8.11	28.21	26.35
Beta Drugs Ltd.	BETA	2,474.26	59.65	7.97	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,416.82	169.49	3.13	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,414	34.44	6.97	-2.6	16.92

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 30.09x compared with the displayed peer median of 39.84x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,13,878.74 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories Ltd.

• Fresh 52-week high at Rs 8,495, indicating strong price momentum.
• Market capitalisation of Rs 2,13,878.74 crore, reflecting significant market presence.
• Valuation metrics show a mixed picture with a P/E of 30.09 and P/B of 0.44.
• Negative ROE and ROCE highlight profitability challenges.
• Competitive sector landscape with opportunities for growth.

About Divi's Laboratories Ltd.

Divi's Laboratories Ltd. is a leading player in the healthcare sector, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company serves a global clientele, providing high-quality products across various therapeutic areas. With a strong emphasis on research and development, Divi's Laboratories Ltd. aims to maintain its competitive edge in the pharmaceutical industry. The company's operations are supported by state-of-the-art manufacturing facilities and a commitment to sustainability and innovation.

Track Divi's Laboratories Ltd. Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Divi's Laboratories Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed about the latest developments and market trends affecting the stock.

Frequently Asked Questions

What is the current share price of Divi's Laboratories Ltd.?

Ans. The current share price of Divi's Laboratories Ltd. is Rs 8,462, reflecting a 5.03% increase from the previous close. The stock moved 5.03% during the session. The intraday range extended from Rs 8,108.1 to Rs 8,495.

What is the 52-week high of Divi's Laboratories Ltd.?

Ans. Divi's Laboratories Ltd. has reached a fresh 52-week high of Rs 8,495, indicating strong market interest. The stock moved 5.03% during the session. The intraday range extended from Rs 8,108.1 to Rs 8,495.

How does Divi's Laboratories Ltd.'s P/E ratio compare to the sector?

Ans. Divi's Laboratories Ltd.'s P/E ratio of 30.09 is above the sector median of 20.73 but below the sector average of 67.98. The company trades at a P/E ratio of 30.09x.

What are the profitability metrics for Divi's Laboratories Ltd.?

Ans. Divi's Laboratories Ltd. has a negative ROE of -2.89% and a negative ROCE of -0.26%, indicating challenges in profitability. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.7%.

What is the market capitalisation of Divi's Laboratories Ltd.?

Ans. The market capitalisation of Divi's Laboratories Ltd. is Rs 2,13,878.74 crore, reflecting its significant market presence. The company operates in the Healthcare sector. Its P/E ratio is 30.09x. ROE is -2.89% and ROCE is -0.26%.

How does Divi's Laboratories Ltd. compare to its peers?

Ans. Divi's Laboratories Ltd. has a similar P/E ratio to Dishman Carbogen Amcis Ltd. but a lower P/B ratio compared to Kwality Pharmaceuticals Ltd. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.

What factors might be driving the share price increase?

Ans. While specific catalysts for the share price increase are not detailed in the available data, factors such as market sentiment, sector performance, or internal company developments could contribute. Investors often look at broader market trends, sector news, and company-specific announcements.

What is the significance of a 52-week high?

Ans. A 52-week high is a technical indicator that represents the highest price at which a stock has traded during the past year. It is often used by investors to gauge a stock's current value and potential future performance. Reaching a.

How does Divi's Laboratories Ltd.'s market cap compare to its peers?

Ans. Divi's Laboratories Ltd. has a market capitalisation of Rs 2,13,878.74 crore, which is significantly higher than its listed peers such as Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd., indicating its larger market presence and influence within the sector.